end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccretionAmortizationOfDiscountsAndPremiumsInvestments,AccruedLiabilitiesCurrent,AccruedSalariesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,AssetsFairValueDisclosure,CapitalExpendituresIncurredButNotYetPaid,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,DeferredCompensationLiabilityClassifiedNoncurrent,DeferredRentCreditNoncurrent,DepreciationDepletionAndAmortization,EarningsPerShareBasicAndDiluted,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized,FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3,FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements,FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue,GeneralAndAdministrativeExpense,ImpairmentOfInvestments,ImpairmentOfLongLivedAssetsHeldForUse,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NumberOfOperatingSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseExpense,OtherAccruedLiabilitiesCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,OtherNonoperatingIncome,PaymentsOfStockIssuanceCosts,PaymentsToAcquireAvailableForSaleSecuritiesDebt,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfPrivatePlacement,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,ProceedsFromStockOptionsExercised,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue,SharePrice,ShortTermInvestments,StockholdersEquity,StockholdersEquityNoteStockSplitConversionRatio1,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,DeferredTaxAssetsGoodwillAndIntangibleAssets,DeferredTaxAssetsGross,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsPropertyPlantAndEquipment,DeferredTaxAssetsTaxCreditCarryforwards,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesPropertyPlantAndEquipment,EarningsPerShareBasic,EarningsPerShareDiluted,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationNondeductibleExpense,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationTaxCredits,ForeignCurrencyTransactionGainLossBeforeTax,GainLossOnSaleOfPropertyPlantEquipment,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,IncomeTaxExaminationPenaltiesAndInterestAccrued,IncomeTaxExpenseBenefit,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,OtherComprehensiveIncomeLossNetOfTax,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfSharesOutstandingBasic
2021-03-31,2021-05-20,10-Q,"RENEO PHARMACEUTICALS, INC.",RPHM,CIK0001637715,USD,556000.0,,3374000.0,514000.0,93000.0,,3453000.0,471000.0,471000.0,19021269.0,95321000.0,93560000.0,89563000.0,2000.0,91221000.0,91221000.0,37608000.0,19138871.0,0.0001,105000000.0,2148193.0,2123733.0,,-7212000.0,,32000.0,10000.0,-3.48,7200000.0,0.0,0.0,0.0,0.0,,,1742000.0,0.0,,-927000.0,929000.0,3962000.0,95321000.0,3930000.0,46222000.0,-25000.0,-8589000.0,-7212000.0,1.0,7214000.0,-7214000.0,46000000.0,704000.0,1680000.0,,2000.0,1223000.0,,25000.0,,,,,2339000.0,,146700000.0,,187000.0,174000.0,81000.0,5472000.0,-52170000.0,471000.0,,0.0,0.712,0.0066,2772210.0,4.4,418000.0,2273285.0,3.15,6086000.0,3113640.0,4.41,1.97,5.06,5441000.0,615517.0,2.49,6.36,,-48717000.0,,95123.0,,139000.0,2070935.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-06-30,2021-08-11,10-Q,"RENEO PHARMACEUTICALS, INC.",RPHM,CIK0001637715,USD,434000.0,,2902000.0,804000.0,103000.0,5000.0,228929000.0,854000.0,854000.0,,171304000.0,171141000.0,,,140368000.0,140368000.0,,5661861.0,0.0001,200000000.0,24305822.0,24288699.0,3000.0,-9211000.0,363000.0,54000.0,10000.0,-0.43,7300000.0,,,,,,363000.0,2949000.0,0.0,,,,3753000.0,171304000.0,3336000.0,,,,-9216000.0,,9228000.0,-9228000.0,,335000.0,78000.0,5000.0,12000.0,,,,0.0001,10000000.0,0.0,0.0,3810000.0,,230600000.0,,,188000.0,85000.0,6279000.0,-61386000.0,,,,,,2784843.0,4.39,,,10.89,15334000.0,3197640.0,4.68,,,13758000.0,,,,26963000.0,167551000.0,,,84533000.0,,21364369.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-12,10-Q,"RENEO PHARMACEUTICALS, INC.",RPHM,CIK0001637715,USD,1271000.0,,5082000.0,1366000.0,116000.0,17000.0,230309000.0,1145000.0,1145000.0,,162943000.0,162665000.0,,,126409000.0,126409000.0,,5520125.0,0.0001,200000000.0,24417558.0,24407722.0,3000.0,-12723000.0,284000.0,98000.0,13000.0,-0.52,7100000.0,,,,,,284000.0,3434000.0,0.0,,,,6735000.0,162943000.0,6353000.0,,,,-12735000.0,,12752000.0,-12752000.0,,686000.0,78000.0,12000.0,17000.0,,,,0.0001,10000000.0,0.0,0.0,4931000.0,,230600000.0,,,316000.0,200000.0,9318000.0,-74121000.0,,300000.0,,,,3215904.0,4.95,,,6.58,8868000.0,3215904.0,4.95,,,8868000.0,,,,31325000.0,156208000.0,,,,220000.0,24396798.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
